CLINICAL_TRIALS
trial_result
· 2011-01-06
Clinical Trial Update: Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab [Phase 2]
Summary
Open-label Phase 2 proof-of-concept study of denosumab in relapsed or plateau-phase multiple myeloma; results were posted in January 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Relapsed or Plateau-Phase Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2011-01-06